Alzheimer’s disease
PrintColloques médecine & recherche
Alzheimer’s disease is today's largest public health challenge, as governments of all countries are discovering to their cost.
Years ago, when the disease was still almost unknown, la Fondation IPSEN was already deeply committed to helping the scientific and medical community to understand its importance. This commitment has not stopped at encouraging the circulation of knowledge: la Fondation IPSEN has also strived to ensure that research into Alzheimer disease and related neurodegenerative conditions benefits from all the progress of modern cellular and molecular biology.
The Fondation IPSEN's 24 Colloques Médecine et Recherche on Alzheimer’s disease have often been the first to deal with the latest discoveries in the field.
Meetings list
- Proteopatics Seeds and Neurodegenerative Diseases
Paris, February 27, 2012 - Protein Quality Control in Neurodegenerative Diseases
Paris, May 9, 2011 - Two Faces of Evil: Cancer and Neurodegeneration
Paris, April 26, 2010 - Diabetes, Insulin and Alzheimer’s disease
Paris, April 6, 2009 - Intracellular Traffic and Neurodegenerative Disorders
Paris, April 28, 2008 - Synaptic Plasticity and the Mechanism of Alzheimer’s Disease
Paris, April 16, 2007 - Alzheimer: 100 Years and Beyond (in collaboration with Tübingen University)
Tübingen, November 2-5, 2006 - Genotype – Proteotype – Phenotype relationships in Neurodegenerative Diseases
Paris, September 13, 2004 - The Living Brain and Alzheimer’s Disease
Paris, March 17, 2003 - Immunization against Alzheimer’s and other Neurodegenerative Diseases
Paris, March 13, 2002 - Notch from Neurodevelopment to Neurodegeneration: Keeping the Fate
Paris, March 19, 2001 - Neurodegenerative Diseases: Loss of Function through Gain of Function
Paris, February 28, 2000 - Fatal Attractions within Neurons: Intracytoplasmic Protein Aggregates in Alzheimer’s Disease and Related Neurodegenerative Disorders
Paris, April 12, 1999 - Epidemiology of Alzheimer’s Disease: from Gene to Prevention
Paris, May 11, 1998 - Presenilins and Alzheimer’s Disease
Paris, April 28, 1997 - Connections, Cognition and Alzheimer’s Disease
Paris, May 20, 1996 - Apolipoprotein E and Alzheimer’s Disease
Paris, May 29, 1995 - Alzheimer’s Disease: Lessons from Cell Biology
Paris, April 25, 1994 - The ß-Amyloid Protein Precursors in Development, Aging and Alzheimer’s Disease
Lyon, June 21, 1993 - Heterogeneity of Alzheimer’s Disease
Marseille, April 6, 1992 - Neurophilosophy and Alzheimer’s Disease
San Diego, January 11, 1991 - Growth Factors and Alzheimer’s Disease
Strasbourg, April 25, 1990 - Imaging, Cerebral Topography and Alzheimer’s Disease
Lille, October 16, 1989 - Biological Markers of Alzheimer’s Disease
Toulouse, April 24, 1989 - Neuronal Grafting and Alzheimer’s Disease: Future Perspectives
Montpellier, September 19, 1988 - Genetics and Alzheimer’s Disease
Paris, March 25, 1988 - Immunological Aspects of Alzheimer’s Disease and Brain Amyloidosis
Angers, September 14, 1987
Alzheimer Actualités
Since 1986, la Fondation Ipsen has published a newsletter dedicated to the Alzheimer’s disease: Alzheimer Actualités (207 editions published), in French only.
Alzheimer Actualités N° 220 January February 2012
Alzheimer Actualités N° 219 November December 2011
Alzheimer Actualités N° 218 September October 2011
Alzheimer Actualités N° 217 July August 2011
Alzheimer Actualités N° 216 May June 2011
Alzheimer Actualités N° 215 March April 2011
Alzheimer Actualités N° 214 January February 2011
Alzheimer Actualités N° 213 November December 2010
Alzheimer Actualités N° 212 September October 2010
Alzheimer Actualités N° 211 July August 2010
Alzheimer Actualités N° 210 May June 2010
Alzheimer Actualités N° 209 March April 2010
Alzheimer Actualités N° 208 January February 2010
Alzheimer Actualités N° 207 November December 2009
Alzheimer Actualités N° 206 September October 2009
Alzheimer Actualités N° 205 July August 2009
Alzheimer Actualités N° 204 May June 2009